Comparison of bronchodilatator response of FEV1 and airway resistance
K. Nietzman-Lammering, K. van der Velden-van Etten, R. Hoek, P. Zanen, H. Stam (Rotterdam, Utrecht, The Netherlands)
Source: Annual Congress 2003 - Assessing airway function: practicalities and clinical applications
Disease area: Airway diseases
Abstract Introduction: Although in COPD patients the reversibility of FEV1 is not significant, patients often feel better after bronchodilatation. Therefore, bronchodilatator responsiveness of FEV1 is compared with that of airway resistance.Method: We performed a reversibility test using 1000 μg Terbutaline. We measured FEV1 with a Lilly type flow transducer and airway resistance with bodyplethysmografie, impulsoscillometry and the interuptor technique respectively. In 73 healthy adults (aged 18 - 78 years) and in 26 adult COPD patients (aged 42 - 79 years) the reversibility of FEV1 was compared with that of Reff , Rtot , R0.5 , R20Hz , R5Hz and Rint . We performed the measurements during one session and in a random order.Results: Reversibility on basis of FEV1 was not significant in normals as well as in COPD patients. In the healthy volunteers the resistance values were not significant lower after bronchodilatation. However, in the group of COPD patients Reff , Rtot , R0,5 and Rint were decreasing significantly. Although the changes in R20Hz and R5Hz were not significant, the difference between R20Hz and R5Hz before and after bronchodilatation appeared to be significant.Conclusion: We observed a significant reversibility of COPD patients, when measured airway resistance with bodyplethysmografie and interruptor technique. The difference between R20Hz and R5Hz before and after bronchodilatation was sensitive to separate COPD from normals, while R20Hz and R5Hz itself were not.
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Nietzman-Lammering, K. van der Velden-van Etten, R. Hoek, P. Zanen, H. Stam (Rotterdam, Utrecht, The Netherlands). Comparison of bronchodilatator response of FEV1 and airway resistance. Eur Respir J 2003; 22: Suppl. 45, 3618
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Influence of basal FEV1 on the response to bronchodilator agents in COPD Source: Eur Respir J 2001; 18: Suppl. 33, 426s Year: 2001
Comparison of FEV1 and specific airway conductance in assessing bronchial response to occupational agents Source: Eur Respir J 2003; 22: Suppl. 45, 488s Year: 2003
IsovolumeFEF25-75% 6 and FEV1 for identifying bronchodilator response Source: Eur Respir J 2006; 28: Suppl. 50, 156s Year: 2006
Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV1 and FEV1 in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005
How often FEV1 underestimates bronchodilator response? Source: Eur Respir J 2003; 22: Suppl. 45, 100s Year: 2003
Can the interrupter resistance be used to measure airway hyperresponsiveness during the methacholine challenge test as a substitute for FEV1? Source: Virtual Congress 2021 – New insights into lung function testing Year: 2021
Airway resistance variability and response to bronchodilator in children with asthma Source: Eur Respir J 2007; 30: 260-268 Year: 2007
sGaw as an alternative for FEV1 in the measurement of airway responsiveness to methacholine in patients experiencing chronic cough Source: Annual Congress 2011 - Lung function today and tomorrow I Year: 2011
Maximally attained level of FEV1 and FEV1 decline determine airway hyperresponsiveness in adults Source: Eur Respir J 2003; 22: Suppl. 45, 17s Year: 2003
FEV1 and respiratory resistance response to methacholine in children calculated from between-measurement variability Source: Eur Respir J 2005; 26: Suppl. 49, 43s Year: 2005
Characterization of bronchodilator response by spirometry and plethismography Source: Annual Congress 2012 - Going with the flow: assessment and evaluation of airway function and its role in patient management Year: 2012
Assessment of bronchial hyperreactivity, maximal airway response and response to inhaled corticosteriod treatment in patients with bronchiectasis Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
Comparison of FEV1 and PEF values in cough variant asthma during methacholine challenge test Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010
Airway calibre variability by forced oscillation technique: a sensitive indicator of bronchodilator effect in asthmatic children Source: Annual Congress 2005 - Monitoring paediatric asthma Year: 2005
Normal lung function and absence of bronchodilator response in children with stable, controlled asthma using inhaled corticosteroids Source: Annual Congress 2006 - New features of paediatric asthma Year: 2006
Comparison of sensitivity and variability of sGaw and FEV1 for measuring bronchodilation in healthy and asthmatic subjects Source: Eur Respir J 2004; 24: Suppl. 48, 338s Year: 2004
Comparison of FEV1 and mid flow parameters as markers of bronchial hyper responsiveness to methacholine Source: Eur Respir J 2003; 22: Suppl. 45, 276s Year: 2003
Comparison of bronchodilator responsiveness between forced oscillation technique and spirometry Source: International Congress 2018 – Improvements in the assessment of paediatric physiology Year: 2018
A comparison of the response to inhaled histamine measured with FEV1 and sGaw in healthy subjects Source: Annual Congress 2003 - Assessing airway function: practicalities and clinical applications Year: 2003